Gene · 2017
Papers4,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 4,431
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dietary patterns in association with the expression of pro-metastatic genes in primary breast cancer. | Eur J Nutr | 2022 | 35484415 | PubTator, text mining | PubMed |
| Disrupting the HDAC6-ubiquitin interaction impairs infection by influenza and Zika virus and cellular stress pathways. | Cell Rep | 2022 | 35476995 | PubTator, text mining | PubMed |
| FGF19 Is Coamplified With CCND1 to Promote Proliferation in Lung Squamous Cell Carcinoma and Their Combined Inhibition Shows Improved Efficacy. | Front Oncol | 2022 | 35463335 | PubTator, text mining | PubMed |
| Serum expression of Vascular Endothelial-Cadherin, CD44, Human High mobility group B1, Kallikrein 6 proteins in different stages of laryngeal intraepithelial lesions and early glottis cancer. | PeerJ | 2022 | 35462765 | PubTator, text mining | PubMed |
| A seven-autophagy-related gene signature for predicting the prognosis of differentiated thyroid carcinoma. | World J Surg Oncol | 2022 | 35459137 | PubTator, text mining | PubMed |
| Natural Bioactive Compounds Targeting Histone Deacetylases in Human Cancers: Recent Updates. | Molecules | 2022 | 35458763 | PubTator, text mining | PubMed |
| Text-Mining Approach to Identify Hub Genes of Cancer Metastasis and Potential Drug Repurposing to Target Them. | J Clin Med | 2022 | 35456223 | PubTator, text mining | PubMed |
| Equid Alphaherpesvirus 1 Modulates Actin Cytoskeleton and Inhibits Migration of Glioblastoma Multiforme Cell Line A172. | Pathogens | 2022 | 35456075 | PubTator, text mining | PubMed |
| The Prognostic Signature of Head and Neck Squamous Cell Carcinoma Constructed by Immune-Related RNA-Binding Proteins. | Front Oncol | 2022 | 35449571 | PubTator, text mining | PubMed |
| Tumor suppressor BAP1 nuclear import is governed by transportin-1. | J Cell Biol | 2022 | 35446349 | PubTator, text mining | PubMed |
| Clinical Impact of 11q13.3 Amplification on Immune Cell Infiltration and Prognosis in Breast Cancer. | Int J Gen Med | 2022 | 35444456 | PubTator, text mining | PubMed |
| Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes. | Nat Commun | 2022 | 35440587 | PubTator, text mining | PubMed |
| A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor. | Mol Cancer Ther | 2022 | 35439318 | PubTator, text mining | PubMed |
| Prenatal Exposures to Common Phthalates and Prevalent Phthalate Alternatives and Infant DNA Methylation at Birth. | Front Genet | 2022 | 35432478 | PubTator, text mining | PubMed |
| Cellular mechanism of action of 2-nitroimidazoles as hypoxia-selective therapeutic agents. | Redox Biol | 2022 | 35430547 | PubTator, text mining | PubMed |
| Megakaryocytes form linear podosomes devoid of digestive properties to remodel medullar matrix. | Sci Rep | 2022 | 35428815 | PubTator, text mining | PubMed |
| Silencing LncRNA CASC9 inhibits proliferation and invasion of colorectal cancer cells by MiR-542-3p/ILK. | PLoS One | 2022 | 35427373 | PubTator, text mining | PubMed |
| Pressure and stiffness sensing together regulate vascular smooth muscle cell phenotype switching. | Sci Adv | 2022 | 35427166 | PubTator, text mining | PubMed |
| Analysis of nAChR Autoantibodies Against Extracellular Epitopes in MG Patients. | Front Neurol | 2022 | 35418927 | PubTator, text mining | PubMed |
| To detect potential pathways and target genes in infantile Pompe patients using computational analysis. | Bioimpacts | 2022 | 35411297 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2017/papers?page=36